Neuronetics (STIM) Equity Ratio (2017 - 2026)

Neuronetics (STIM) has 10 years of Equity Ratio data on file, last reported at 0.11 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.11, down 62.02% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11 (down 62.02% YoY), and the FY2025 annual result was 0.19, down 17.86% from the prior year.
• Equity Ratio retreated to 0.11 in Q1 2026 per STIM's latest filing, from 0.19 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.59 in Q1 2022 and troughed at 0.11 in Q1 2026.
• A 5-year average of 0.33 and a median of 0.28 in 2025 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio plunged 68.98% in 2024, then jumped 48.58% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.49 in 2022, then plunged by 39.54% to 0.3 in 2023, then declined by 23.54% to 0.23 in 2024, then declined by 17.86% to 0.19 in 2025, then sank by 42.95% to 0.11 in 2026.
• Business Quant data shows STIM's Equity Ratio at 0.11 in Q1 2026, 0.19 in Q4 2025, and 0.19 in Q3 2025.